Double-blind, multi-centre parallel trial of ketoprofen and ibuprofen in the treatment of rheumatoid arthritis. 1977

A Calin, and R M Bennett, and S Sukhupunyaraksa, and A L Goldman, and H E Montoya, and W M O'Brien, and V J Giuliano, and F R Schmid, and R F Willkens, and H Y Sakofsky

A double-blind parallel multi-centre study of 102 patients with rheumatoid arthritis (RA) was performed, comparing ibuprofen (1200-2400 mg daily) and ketoprofen (150-300 mg daily) a new non-steroidal, anti-inflammatory agent, over a three month period. Ketoprofen was well tolerated and shown to have comparable efficacy with ibuprofen. Longterm efficacy and tolerance studies are indicated.

UI MeSH Term Description Entries
D007052 Ibuprofen A non-steroidal anti-inflammatory agent with analgesic, antipyretic, and anti-inflammatory properties Advil,Benzeneacetic Acid, alpha-methyl-4-(2-methylpropyl)- trimethylsilyl ester,Brufen,Ibumetin,Ibuprofen, (+-)-Isomer,Ibuprofen, (R)-Isomer,Ibuprofen, (S)-Isomer,Ibuprofen, Aluminum Salt,Ibuprofen, Calcium Salt,Ibuprofen, Copper (2+) Salt,Ibuprofen, Magnesium Salt,Ibuprofen, Potassium Salt,Ibuprofen, Sodium Salt,Ibuprofen, Zinc Salt,Ibuprofen-Zinc,Motrin,Nuprin,Rufen,Salprofen,Trauma-Dolgit Gel,alpha-Methyl-4-(2-methylpropyl)benzeneacetic Acid,Ibuprofen Zinc,Trauma Dolgit Gel
D007660 Ketoprofen An IBUPROFEN-type anti-inflammatory analgesic and antipyretic. It is used in the treatment of rheumatoid arthritis and osteoarthritis. Benzoylhydratropic Acid,19,583 RP,2-(3-Benzoylphenyl)propionic Acid,Alrheumat,Alrheumum,Orudis,Profenid,RP-19583,RP 19583,RP, 19,583,RP19583
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010666 Phenylpropionates Derivatives of 3-phenylpropionic acid, including its salts and esters.
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

A Calin, and R M Bennett, and S Sukhupunyaraksa, and A L Goldman, and H E Montoya, and W M O'Brien, and V J Giuliano, and F R Schmid, and R F Willkens, and H Y Sakofsky
October 1973, British medical journal,
A Calin, and R M Bennett, and S Sukhupunyaraksa, and A L Goldman, and H E Montoya, and W M O'Brien, and V J Giuliano, and F R Schmid, and R F Willkens, and H Y Sakofsky
January 1976, Scandinavian journal of rheumatology. Supplement,
A Calin, and R M Bennett, and S Sukhupunyaraksa, and A L Goldman, and H E Montoya, and W M O'Brien, and V J Giuliano, and F R Schmid, and R F Willkens, and H Y Sakofsky
January 1970, Rheumatology and physical medicine,
A Calin, and R M Bennett, and S Sukhupunyaraksa, and A L Goldman, and H E Montoya, and W M O'Brien, and V J Giuliano, and F R Schmid, and R F Willkens, and H Y Sakofsky
April 1975, European journal of clinical pharmacology,
A Calin, and R M Bennett, and S Sukhupunyaraksa, and A L Goldman, and H E Montoya, and W M O'Brien, and V J Giuliano, and F R Schmid, and R F Willkens, and H Y Sakofsky
January 1973, Scandinavian journal of rheumatology. Supplement,
A Calin, and R M Bennett, and S Sukhupunyaraksa, and A L Goldman, and H E Montoya, and W M O'Brien, and V J Giuliano, and F R Schmid, and R F Willkens, and H Y Sakofsky
July 1981, The New Zealand medical journal,
A Calin, and R M Bennett, and S Sukhupunyaraksa, and A L Goldman, and H E Montoya, and W M O'Brien, and V J Giuliano, and F R Schmid, and R F Willkens, and H Y Sakofsky
October 1969, The Medical journal of Australia,
A Calin, and R M Bennett, and S Sukhupunyaraksa, and A L Goldman, and H E Montoya, and W M O'Brien, and V J Giuliano, and F R Schmid, and R F Willkens, and H Y Sakofsky
May 1979, Rheumatology and rehabilitation,
A Calin, and R M Bennett, and S Sukhupunyaraksa, and A L Goldman, and H E Montoya, and W M O'Brien, and V J Giuliano, and F R Schmid, and R F Willkens, and H Y Sakofsky
January 1976, Scandinavian journal of rheumatology. Supplement,
A Calin, and R M Bennett, and S Sukhupunyaraksa, and A L Goldman, and H E Montoya, and W M O'Brien, and V J Giuliano, and F R Schmid, and R F Willkens, and H Y Sakofsky
January 1970, Rheumatology and physical medicine,
Copied contents to your clipboard!